Mechanisms of Resistance to TKI in NSCLC

CRSF 7th Masterclass | Resistance to RET TKI & Post-Resistance Therapy by Dr. Vibhor SharmaПодробнее

2023 Best of Lung: Targeted Therapies in Lung CancerПодробнее

CRSF 07th Masterclass: Mechanism of Resistance to Osimertinib in EGFR Mutated Lung Cancer|Dr. MandalПодробнее

Mechanisms of resistance to EGFR tyrosine kinase inhibitors | RTCL.TVПодробнее

RET - Dr Akhil Kapoor - Mechanism Of Resistance To RET TKI And Therapy Post ResistanceПодробнее

Dr Pritam Kataria - Mechanism Of Resistance To KRAS TKI And Therapy Post ResistanceПодробнее

Mechanisms of resistance to EGFR tyrosine kinase inhibitors | RTCL.TVПодробнее

The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms ... | RTCL.TVПодробнее

CRSF 07th Masterclass: Mechanisms of Resistance to ALK Inhibitors | Dr. Nandini MenonПодробнее

ALK Positive Lung Cancer in 2023 and Beyond: Thinking Outside the Box with Dr. Alice ShawПодробнее

Dr Sudeep Das - Mechanism Of Resistance To MET TKI And Therapy Post Resistance IN NSCLCПодробнее

EGFR TKI Resistance: Progress and ChallengesПодробнее

ROS - Dr Raajit Chaana - Mechanism Of Resistance To ROS 1and Therapy Post Resistance In NSCLCПодробнее

ILCN Multidisciplinary Forum: Understanding Treatment Options and Resistance in EGFR-positive NSCLCПодробнее

Dr Mounika Boppana - Mechanism Of Resistance To EXON 20 Insertion TKI And Therapy Post ResistanceПодробнее

Clinical applications of liquid biopsy in non-small-cell lung cancerПодробнее

Dr Nandini Menon - Molecular Resistance Mechanism Of ALK InhibitorsПодробнее

Dr Rakesh Pinninti - Mechanism Of Resistance To BRAF TKI And Therapy Post Resistance In BRAF MutaПодробнее

Dr Chakor Vora - Mechanism Of Resistance To Osimeritinib In EGFR Mutated Lung CancerПодробнее

Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLCПодробнее